These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24724042)

  • 1. A Comparative White Matter Study with Parkinson's disease, Parkinson's Disease with Dementia and Alzheimer's Disease.
    Perea RD; Rada RC; Wilson J; Vidoni1 ED; Morris JK; Lyons KE; Pahwa R; Burns JM; Honea RA
    J Alzheimers Dis Parkinsonism; 2013 Aug; 3():123. PubMed ID: 24724042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifocal alterations of white matter accompany the transition from normal cognition to dementia in Parkinson's disease patients.
    Chondrogiorgi M; Astrakas LG; Zikou AK; Weis L; Xydis VG; Antonini A; Argyropoulou MI; Konitsiotis S
    Brain Imaging Behav; 2019 Feb; 13(1):232-240. PubMed ID: 29629498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between cognitive impairment and white-matter alteration in Parkinson's disease with dementia: tract-based spatial statistics and tract-specific analysis.
    Kamagata K; Motoi Y; Tomiyama H; Abe O; Ito K; Shimoji K; Suzuki M; Hori M; Nakanishi A; Sano T; Kuwatsuru R; Sasai K; Aoki S; Hattori N
    Eur Radiol; 2013 Jul; 23(7):1946-55. PubMed ID: 23404139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations of mean diffusivity in brain white matter and deep gray matter in Parkinson's disease.
    Kim HJ; Kim SJ; Kim HS; Choi CG; Kim N; Han S; Jang EH; Chung SJ; Lee CS
    Neurosci Lett; 2013 Aug; 550():64-8. PubMed ID: 23831353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of White Matter Lesions in Parkinson's Disease: Voxel-based Analysis and Tract-based Spatial Statistics Analysis of Parkinson's Disease with Mild Cognitive Impairment.
    Pu W; Shen X; Huang M; Li Z; Zeng X; Wang R; Shen G; Yu H
    Curr Neurovasc Res; 2020; 17(4):480-486. PubMed ID: 32875986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between white matter microstructure and amyloid burden in preclinical Alzheimer's disease: A multimodal imaging investigation.
    Racine AM; Adluru N; Alexander AL; Christian BT; Okonkwo OC; Oh J; Cleary CA; Birdsill A; Hillmer AT; Murali D; Barnhart TE; Gallagher CL; Carlsson CM; Rowley HA; Dowling NM; Asthana S; Sager MA; Bendlin BB; Johnson SC
    Neuroimage Clin; 2014; 4():604-14. PubMed ID: 24936411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of diffusion tensor imaging and fractional anisotropy in the evaluation of patients with idiopathic normal pressure hydrocephalus: a literature review.
    Siasios I; Kapsalaki EZ; Fountas KN; Fotiadou A; Dorsch A; Vakharia K; Pollina J; Dimopoulos V
    Neurosurg Focus; 2016 Sep; 41(3):E12. PubMed ID: 27581308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. White matter abnormalities in the corpus callosum with cognitive impairment in Parkinson disease.
    Bledsoe IO; Stebbins GT; Merkitch D; Goldman JG
    Neurology; 2018 Dec; 91(24):e2244-e2255. PubMed ID: 30429273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of striatonigral connectivity using probabilistic tractography in Parkinson's disease.
    Theisen F; Leda R; Pozorski V; Oh JM; Adluru N; Wong R; Okonkwo O; Dean DC; Bendlin BB; Johnson SC; Alexander AL; Gallagher CL
    Neuroimage Clin; 2017; 16():557-563. PubMed ID: 28971007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive Decline in Gray and White Matter Integrity in
    Taylor KI; Sambataro F; Boess F; Bertolino A; Dukart J
    Front Aging Neurosci; 2018; 10():318. PubMed ID: 30349475
    [No Abstract]   [Full Text] [Related]  

  • 11. Diffusion tensor imaging techniques show that parkin gene S/N167 polymorphism is responsible for extensive brain white matter damage in patients with Parkinson's disease.
    Yu J; Shi J; Chen L; Wang Y; Cai G; Chen X; Hong W; Ye Q
    Heliyon; 2023 Aug; 9(8):e18395. PubMed ID: 37600423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. White matter microstructure damage in tremor-dominant Parkinson's disease patients.
    Luo C; Song W; Chen Q; Yang J; Gong Q; Shang HF
    Neuroradiology; 2017 Jul; 59(7):691-698. PubMed ID: 28540401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive profiles and optimal cut-offs for routine cognitive tests in elderly individuals with Parkinson's disease, Parkinson's disease dementia, Alzheimer's disease, and normal cognition.
    Phannarus H; Muangpaisan W; Siritipakorn P; Chotinaiwattarakul W
    Psychogeriatrics; 2020 Jan; 20(1):20-27. PubMed ID: 30912230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. White matter integrity and cognition in Parkinson's disease: a cross-sectional study.
    Auning E; Kjærvik VK; Selnes P; Aarsland D; Haram A; Bjørnerud A; Hessen E; Esnaashari A; Fladby T
    BMJ Open; 2014 Jan; 4(1):e003976. PubMed ID: 24448846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex ratio in dementia with Lewy bodies balanced between Alzheimer's disease and Parkinson's disease dementia: a cross-sectional study.
    Mouton A; Blanc F; Gros A; Manera V; Fabre R; Sauleau E; Gomez-Luporsi I; Tifratene K; Friedman L; Thümmler S; Pradier C; Robert PH; David R
    Alzheimers Res Ther; 2018 Sep; 10(1):92. PubMed ID: 30208961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corpus callosum in neurodegenerative diseases: findings in Parkinson's disease.
    Wiltshire K; Foster S; Kaye JA; Small BJ; Camicioli R
    Dement Geriatr Cogn Disord; 2005; 20(6):345-51. PubMed ID: 16192724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring quantitative group-wise differentiation of Alzheimer's disease and behavioural variant frontotemporal dementia using tract-specific microstructural white matter and functional connectivity measures at multiple time points.
    Meijboom R; Steketee RME; Ham LS; Mantini D; Bron EE; van der Lugt A; van Swieten JC; Smits M
    Eur Radiol; 2019 Oct; 29(10):5148-5159. PubMed ID: 30859283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. White matter hyperintensities on MRI in dementia with Lewy bodies, Parkinson's disease with dementia, and Alzheimer's disease.
    Joki H; Higashiyama Y; Nakae Y; Kugimoto C; Doi H; Kimura K; Kishida H; Ueda N; Nakano T; Takahashi T; Koyano S; Takeuchi H; Tanaka F
    J Neurol Sci; 2018 Feb; 385():99-104. PubMed ID: 29406924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.
    Burton EJ; McKeith IG; Burn DJ; Williams ED; O'Brien JT
    Brain; 2004 Apr; 127(Pt 4):791-800. PubMed ID: 14749292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropathological distinction between Parkinson's dementia and Parkinson's plus Alzheimer's disease.
    de la Monte SM; Wells SE; Hedley-Whyte T; Growdon JH
    Ann Neurol; 1989 Sep; 26(3):309-20. PubMed ID: 2802531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.